Ageo, Japan

Takeo Iwakuma


Average Co-Inventor Count = 4.8

ph-index = 4

Forward Citations = 53(Granted Patents)


Company Filing History:


Years Active: 1986-1993

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Takeo Iwakuma: Innovator in Pharmaceutical Chemistry

Introduction

Takeo Iwakuma is a distinguished inventor based in Ageo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for treating thromboses and asthma. With a total of 7 patents to his name, Iwakuma's work has had a profound impact on medical treatments.

Latest Patents

Iwakuma's latest patents include innovative methods and compounds aimed at addressing serious health conditions. One notable patent describes indan derivatives used for treating thromboses or asthma. This method involves administering an effective amount of a compound with a specific chemical formula to warm-blooded animals. The compound includes various substituents that enhance its therapeutic efficacy. Another patent focuses on indan derivatives that serve as platelet aggregation-inhibiting agents. These compounds are designed to treat and prevent a range of conditions, including thrombosis, embolism, and asthma.

Career Highlights

Iwakuma is currently associated with Tanabe Seiyaku Company, Limited, where he continues to innovate in the pharmaceutical sector. His work has not only advanced scientific understanding but has also led to practical applications that benefit patients worldwide.

Collaborations

Throughout his career, Iwakuma has collaborated with notable colleagues, including Yasuhiko Sasaki and Katsuo Ikezawa. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.

Conclusion

Takeo Iwakuma's contributions to pharmaceutical chemistry exemplify the spirit of innovation in the medical field. His patents reflect a commitment to improving health outcomes through scientific research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…